Trial
NCT00729807
0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
National Cancer Institute (NCI)
Condition
Melanoma (Skin)
Intervention
pentamidine
Why stopped
Study was closed at the suggestion of DSMB prior to obtaining target enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-16